$CEAD
CEA Industries Inc. Stock $cead

$cead Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000149315223009274 Filed on March 28, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$4.683M	$1.461M	$11.28M
YoY Change	168.43%	-52.2%	-17.27%
Cost Of Revenue	$3.829M	$1.310M	$10.14M
YoY Change	131.53%	-47.7%	-5.36%
Gross Profit	$853.3K	$151.0K	$1.145M
YoY Change	842.74%	-72.64%	-60.87%
Gross Profit Margin	18.22%	10.34%	10.15%
Selling, General & Admin	$1.021M	$1.368M	$4.760M
YoY Change	-34.69%	-0.25%	7.33%
% of Gross Profit	119.62%	905.83%	415.73%
Research & Development	$76.41K	$65.51K	$320.0K
YoY Change	-44.99%	-55.41%	-31.87%
% of Gross Profit	8.96%	43.38%	27.95%
Depreciation & Amortization	$7.500K	$7.710K	$32.44K
YoY Change	-12.38%	-25.87%	-50.37%
% of Gross Profit	0.88%	5.11%	2.83%
Operating Expenses	$1.299M	$1.433M	$6.869M
YoY Change	-23.64%	-5.59%	40.05%
Operating Profit	-$446.2K	-$1.282M	-$5.724M
YoY Change	-72.31%	32.7%	189.3%
Interest Expense	$9.020K	$10.73K	$70.31K
YoY Change	176.69%	2338.64%	-2584.45%
% of Operating Profit
Other Income/Expense, Net	$14.72K	$0.00	$226.7K
YoY Change	-92.04%	-100.0%	240.4%
Pretax Income	-$431.4K	-$1.272M	-$5.497M
YoY Change	-69.68%	216.4%	310.87%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$431.4K	-$1.272M	-$5.497M
YoY Change	-69.68%	216.4%	310.87%
Net Earnings / Revenue	-9.21%	-87.05%	-48.72%
Basic Earnings Per Share	-$0.05		-$0.84
Diluted Earnings Per Share	-$0.05	-$0.16	-$0.84
COMMON SHARES
Basic Shares Outstanding	8.076M shares	7.954M shares	7.094M shares
Diluted Shares Outstanding	8.072M shares		7.094M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$15.95M	$18.64M	$18.64M
YoY Change	-27.62%	762.98%	762.98%
Cash & Equivalents	$15.95M	$18.64M
Short-Term Investments
Other Short-Term Assets	$471.1K	$1.490M	$1.490M
YoY Change	-73.45%	16.97%	16.97%
Inventory	$441.1K	$348.4K	$348.4K
Prepaid Expenses
Receivables	$61.77K	$2.649K	$2.650K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$16.92M	$20.48M	$20.48M
YoY Change	-32.46%	413.09%	413.09%
LONG-TERM ASSETS
Property, Plant & Equipment	$60.71K	$68.51K	$531.4K
YoY Change	-90.17%	-11.42%	-17.39%
Goodwill
YoY Change
Intangibles		$1.830K
YoY Change		0.0%
Long-Term Investments
YoY Change
Other Assets	$14.75K	$14.75K	$14.75K
YoY Change	0.0%	0.0%	0.0%
Total Long-Term Assets	$513.8K	$548.0K	$548.0K
YoY Change	-59.39%	-57.55%	-57.55%
TOTAL ASSETS
Total Short-Term Assets	$16.92M	$20.48M	$20.48M
Total Long-Term Assets	$513.8K	$548.0K	$548.0K
Total Assets	$17.44M	$21.03M	$21.03M
YoY Change	-33.76%	298.07%	298.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$714.6K	$311.2K	$311.2K
YoY Change	-1.98%	-49.49%	-49.49%
Accrued Expenses	$569.8K	$1.104M	$1.104M
YoY Change	-33.41%	20.91%	20.91%
Deferred Revenue	$1.103M	$4.339M
YoY Change		52.78%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.387M	$5.754M	$5.754M
YoY Change	-66.41%	30.59%	30.59%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$348.2K	$376.9K	$376.9K
YoY Change	-24.22%		-22.5%
Total Long-Term Liabilities	$348.2K	$376.9K	$376.9K
YoY Change	-24.22%	-22.49%	-22.5%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.387M	$5.754M	$5.754M
Total Long-Term Liabilities	$348.2K	$376.9K	$376.9K
Total Liabilities	$2.735M	$6.131M	$6.131M
YoY Change	-63.85%	25.31%	25.31%
SHAREHOLDERS EQUITY
Retained Earnings	-$34.71M	-$34.28M
YoY Change		19.1%
Common Stock	$81.00	$80.00
YoY Change		400.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$14.70M	$14.90M	$14.90M
YoY Change
Total Liabilities & Shareholders Equity	$17.44M	$21.03M	$21.03M
YoY Change	-33.76%	298.07%	298.07%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$431.4K	-$1.272M	-$5.497M
YoY Change	-69.68%	216.4%	310.87%
Depreciation, Depletion And Amortization	$7.500K	$7.710K	$32.44K
YoY Change	-12.38%	-25.87%	-50.37%
Cash From Operating Activities	-$2.689M	-$2.446M	-$3.190M
YoY Change	-1494.4%	69.19%	-0.55%
INVESTING ACTIVITIES
Capital Expenditures		$0.00	$30.35K
YoY Change		-100.0%	-144.2%
Acquisitions
YoY Change
Other Investing Activities	$200.00	$0.00	$2.250K
YoY Change		-100.0%	-80.43%
Cash From Investing Activities	$200.00	$0.00	-$28.10K
YoY Change	-101.43%	-100.0%	-50.84%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		0.000	$19.70M
YoY Change		-100.0%	527.42%
NET CHANGE
Cash From Operating Activities	-$2.689M	-2.446M	-$3.190M
Cash From Investing Activities	$200.00	0.000	-$28.10K
Cash From Financing Activities		0.000	$19.70M
Net Change In Cash	-$2.689M	-2.446M	$16.48M
YoY Change	-113.53%	1868.64%	-13252.54%
FREE CASH FLOW
Cash From Operating Activities	-$2.689M	-$2.446M	-$3.190M
Capital Expenditures		$0.00	$30.35K
Free Cash Flow	-$2.689M	-$2.446M	-$3.220M
YoY Change	-1400.34%	75.67%	2.59%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001482541
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022Q4	us-gaap	Goodwill Goodwill		usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Carrying Amount RedeemableNoncontrollingInterestEquityPreferredCarryingAmount		usd
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment		usd
CY2022	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	CEAD	Convertible Preferred Stock Redemption Value Adjustment ConvertiblePreferredStockRedemptionValueAdjustment		usd
CY2022	CEAD	Dividend On Redemption Of Preferred Stock DividendOnRedemptionOfPreferredStock		usd
CY2021	CEAD	Deemed Dividend Preferred Stock On Down Round DeemedDividendPreferredStockOnDownRound		usd
CY2021	CEAD	Conversion Of Series Preferred Stock To Common ConversionOfSeriesPreferredStockToCommon		usd
CY2022	CEAD	Stock Issued During Period Value Reverse Stock Splits StockIssuedDuringPeriodValueReverseStockSplits		usd
CY2022	CEAD	Stock Issued During Period Value Cashless Exercise Of Prefunded Warrants StockIssuedDuringPeriodValueCashlessExerciseOfPrefundedWarrants		usd
CY2022	CEAD	Gain On Forgiveness Of Note Payable GainOnForgivenessOfNotePayable		usd
CY2022	CEAD	Common Stock Issued For Other Expense CommonStockIssuedForOtherExpense		usd
CY2022	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease		usd
CY2021	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment		usd
CY2022	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet		usd
CY2022	CEAD	Increase Decrease In Operating Deposit IncreaseDecreaseInOperatingDeposit		usd
CY2021	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock		usd
CY2021	CEAD	Payments For Redemption Of Preferred Stock PaymentsForRedemptionOfPreferredStock		usd
CY2021	CEAD	Cash Proceeds From Sale Of Common Stock And Warrants Net Of Issuance Costs CashProceedsFromSaleOfCommonStockAndWarrantsNetOfIssuanceCosts		usd
CY2022	CEAD	Cash Proceeds From Sale Of Preferred Stock And Warrants Net Of Issuance Costs CashProceedsFromSaleOfPreferredStockAndWarrantsNetOfIssuanceCosts		usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	CEAD	Adjustment Of Carrying Value Of Series B Preferred Stock To Redemption Value AdjustmentOfCarryingValueOfSeriesBPreferredStockToRedemptionValue		usd
CY2021	CEAD	Noncash Investing And Financing Activities Conversion Of Series B Preferred Stock NoncashInvestingAndFinancingActivitiesConversionOfSeriesBPreferredStock		usd
CY2022	CEAD	Accrued Series B Dividend Payable Settled In Shares Of Common Stock AccruedSeriesBDividendPayableSettledInSharesOfCommonStock		usd
CY2022	CEAD	Series Preferred Stock Converted Into Shares Of Common Stock SeriesPreferredStockConvertedIntoSharesOfCommonStock		usd
CY2021	CEAD	Noncash Investing And Financing Activities Deemed Dividend Preferred Stock Arising On Down Round NoncashInvestingAndFinancingActivitiesDeemedDividendPreferredStockArisingOnDownRound		usd
CY2022	CEAD	Noncash Dividend On Redemption Of Series Preferred Stock Settled In Shares Of Common Stock NoncashDividendOnRedemptionOfSeriesPreferredStockSettledInSharesOfCommonStock		usd
CY2022	CEAD	Right Of Use Asset Arising On New Office Lease RightOfUseAssetArisingOnNewOfficeLease		usd
CY2021	CEAD	Cashless Exercise Or Prepaid Warrants CashlessExerciseOrPrepaidWarrants		usd
CY2022Q4	CEAD	Remaining Performance Obligations Related To Engineering Only Paid Contracts RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts		usd
CY2020Q4	CEAD	Class Of Warrant Or Right Outstanding Aggregate Intrinsic Value ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue		usd
CY2021	CEAD	Class Of Warrant Or Right Issued Aggregate Intrinsic Value ClassOfWarrantOrRightIssuedAggregateIntrinsicValue		usd
CY2021	CEAD	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised		shares
CY2021	CEAD	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExercised		shares
CY2021	CEAD	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Exercised Weighted Average Remaining Contractual Terms SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms
CY2021	CEAD	Class Of Warrant Or Right Exercised Aggregate Intrinsic Value ClassOfWarrantOrRightExercisedAggregateIntrinsicValue		usd
CY2021	CEAD	Class Of Warrant Or Right Expired Aggregate Intrinsic Value ClassOfWarrantOrRightExpiredAggregateIntrinsicValue		usd
CY2022	CEAD	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Exercised Weighted Average Remaining Contractual Terms SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations		shares
CY2022	CEAD	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExpirations		shares
CY2022	CEAD	Class Of Warrant Or Right Weighted Average Exercise Price Expired ClassOfWarrantOrRightWeightedAverageExercisePriceExpired
CY2022	CEAD	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Expirations SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpirations		usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-41266
CY2022	dei	Entity Registrant Name EntityRegistrantName	CEA INDUSTRIES INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-3911608
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	385 South Pierce Avenue
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite C
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Louisville
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80027
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80027
CY2022	dei	City Area Code CityAreaCode	(303)
CY2022	dei	Local Phone Number LocalPhoneNumber	993-5271
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	10007535	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	8076372	shares
CY2022	dei	Auditor Firm AuditorFirmId	3627
CY2022	dei	Auditor Name AuditorName	Sadler, Gibb & Associates, LLC
CY2022	dei	Auditor Location AuditorLocation	Draper, UT
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18637114	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2159608	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2649	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	179444	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	348411	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	378326	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1489921	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1273720	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	20478095	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	3991098	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	68513	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	77346	usd
CY2021Q4	us-gaap	Goodwill Goodwill	631064	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1830	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1830	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	14747	usd
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	14747	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	462874	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	565877	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	547964	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1290864	usd
CY2022Q4	us-gaap	Assets Assets	21026059	usd
CY2021Q4	us-gaap	Assets Assets	5281962	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1207258	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1345589	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4338570	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2839838	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	89970	usd
CY2021Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	83625	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	37078	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	118235	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	100139	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5754033	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4406269	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	376851	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	486226	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	376851	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	486226	usd
CY2022Q4	us-gaap	Liabilities Liabilities	6130884	usd
CY2021Q4	us-gaap	Liabilities Liabilities	4892495	usd
CY2022Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	3300	shares
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	3300	shares
CY2021Q4	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Carrying Amount RedeemableNoncontrollingInterestEquityPreferredCarryingAmount	3960000	usd
CY2021Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	3960000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	150000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	850000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7953974	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7953974	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1600835	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1600835	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	80	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	16	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	49173836	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	25211017	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34278741	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-28781566	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	14895175	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-3570533	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21026059	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5281962	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11283189	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13638558	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	10138249	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	10712563	usd
CY2022	us-gaap	Gross Profit GrossProfit	1144940	usd
CY2021	us-gaap	Gross Profit GrossProfit	2925995	usd
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1157871	usd
CY2021	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	772139	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	319987	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	469703	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4759865	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3662668	usd
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	631064	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	6868787	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	4904510	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-5723847	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-1978515	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	191358	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	627592	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	35314	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2832	usd
CY2021	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	15832	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	226672	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	640592	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5497175	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1337923	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5497175	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1337923	usd
CY2021	CEAD	Convertible Preferred Stock Redemption Value Adjustment ConvertiblePreferredStockRedemptionValueAdjustment	2262847	usd
CY2022	CEAD	Convertible Preferred Stock Converted To Securities ConvertiblePreferredStockConvertedToSecurities	35984	usd
CY2021	CEAD	Convertible Preferred Stock Converted To Securities ConvertiblePreferredStockConvertedToSecurities	67447	usd
CY2021	CEAD	Dividend On Redemption Of Preferred Stock DividendOnRedemptionOfPreferredStock	20595	usd
CY2022	CEAD	Deemed Dividend Preferred Stock On Down Round DeemedDividendPreferredStockOnDownRound	439999	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5973158	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3688812	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.84
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.33
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7094410	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1582869	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-1333698	usd
CY2021	CEAD	Common Shares Issued In Settlement Of Legal Dispute CommonSharesIssuedInSettlementOfLegalDispute	67000	usd
CY2021	CEAD	Fair Value Of Vested Stock Options Granted To Employees FairValueOfVestedStockOptionsGrantedToEmployees	298040	usd
CY2021	CEAD	Fair Value Of Vested Stock Options Granted To Directors FairValueOfVestedStockOptionsGrantedToDirectors	21174	usd
CY2021	CEAD	Adjustments To Additional Paid In Capital Issuance Of Series B Preferred Stock And Warrants AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants	927721	usd
CY2021	CEAD	Issuance Of Common Stock In Settlement Of Accrued Interest IssuanceOfCommonStockInSettlementOfAccruedInterest	67447	usd
CY2021	CEAD	Issuance Of Restricted Common Stock To Employee IssuanceOfRestrictedCommonStockToEmployee	50000	usd
CY2021	CEAD	Accrued Interest On Series B Preferred Stock AccruedInterestOnSeriesBPreferredStock	-67447	usd
CY2021	CEAD	Adjustments To Additional Paid In Capital Redemption Value AdjustmentsToAdditionalPaidInCapitalRedemptionValue	-2262847	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1337923	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-3570533	usd
CY2022	CEAD	Adjustments To Additional Paid In Capital Fair Value Of Vested Stock Options Granted To Employees AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptionsGrantedToEmployees	229423	usd
CY2022	CEAD	Adjustments To Additional Paid In Capital Fair Value Of Vested Stock Options Granted To Directors AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptionsGrantedToDirectors	29656	usd
CY2022	CEAD	Stock Issued During Period Value Common Shares Issued In Settlement Of Restricted Stock Units Issued To Directors StockIssuedDuringPeriodValueCommonSharesIssuedInSettlementOfRestrictedStockUnitsIssuedToDirectors	24994	usd
CY2022	CEAD	Adjustments To Additional Paid In Capital Fair Value Of Restricted Stock Units Issued To Directors AdjustmentsToAdditionalPaidInCapitalFairValueOfRestrictedStockUnitsIssuedToDirectors	23663	usd
CY2022	CEAD	Common Shares And Warrants Issued Value For Cash CommonSharesAndWarrantsIssuedValueForCash	21711131	usd
CY2022	CEAD	Adjustments To Additional Paid In Capital Dividends On Preferred Stock AdjustmentsToAdditionalPaidInCapitalDividendsOnPreferredStock	-35984	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1980000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5497175	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	14895175	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5497175	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1337923	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	32442	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	65372	usd
CY2021	CEAD	Gain On Forgiveness Of Note Payable GainOnForgivenessOfNotePayable	517032	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	307736	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	369214	usd
CY2021	CEAD	Common Stock Issued For Other Expense CommonStockIssuedForOtherExpense	67000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-54708	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	16844	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	-20472	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	-1666	usd
CY2021	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	15832	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-4489	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-67567	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	103003	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	204521	usd
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	631064	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-231504	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	162808	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-50387	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	49551	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	216202	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	235897	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-175409	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-476450	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1498732	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-884350	usd
CY2021	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	2832	usd
CY2021	CEAD	Increase Decrease In Operating Deposit IncreaseDecreaseInOperatingDeposit	-14747	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-91279	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-259475	usd
CY2022	CEAD	Increase Decrease In Deferred Compensation Accrued Equity Compensation IncreaseDecreaseInDeferredCompensationAccruedEquityCompensation	6345	usd
CY2021	CEAD	Increase Decrease In Deferred Compensation Accrued Equity Compensation IncreaseDecreaseInDeferredCompensationAccruedEquityCompensation	-44809	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3189543	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3207190	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	30348	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	68657	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2250	usd
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	11500	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-28098	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-57157	usd
CY2022	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	35984	usd
CY2022	CEAD	Payments For Redemption Of Preferred Stock PaymentsForRedemptionOfPreferredStock	1980000	usd
CY2022	CEAD	Cash Proceeds From Sale Of Common Stock And Warrants Net Of Issuance Costs CashProceedsFromSaleOfCommonStockAndWarrantsNetOfIssuanceCosts	21711131	usd
CY2021	CEAD	Cash Proceeds From Sale Of Preferred Stock And Warrants Net Of Issuance Costs CashProceedsFromSaleOfPreferredStockAndWarrantsNetOfIssuanceCosts	2624874	usd
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	514200	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19695147	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3139074	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	16477506	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-125273	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2159608	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2284881	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	18637114	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2159608	usd
CY2021	CEAD	Adjustment Of Carrying Value Of Series B Preferred Stock To Redemption Value AdjustmentOfCarryingValueOfSeriesBPreferredStockToRedemptionValue	2262847	usd
CY2022	CEAD	Noncash Investing And Financing Activities Conversion Of Series B Preferred Stock NoncashInvestingAndFinancingActivitiesConversionOfSeriesBPreferredStock	1980000	usd
CY2021	CEAD	Accrued Series B Dividend Payable Settled In Shares Of Common Stock AccruedSeriesBDividendPayableSettledInSharesOfCommonStock	67447	usd
CY2021	CEAD	Series Preferred Stock Converted Into Shares Of Common Stock SeriesPreferredStockConvertedIntoSharesOfCommonStock	420	usd
CY2022	CEAD	Noncash Investing And Financing Activities Deemed Dividend Preferred Stock Arising On Down Round NoncashInvestingAndFinancingActivitiesDeemedDividendPreferredStockArisingOnDownRound	439999	usd
CY2021	CEAD	Noncash Dividend On Redemption Of Series Preferred Stock Settled In Shares Of Common Stock NoncashDividendOnRedemptionOfSeriesPreferredStockSettledInSharesOfCommonStock	20595	usd
CY2021	CEAD	Right Of Use Asset Arising On New Office Lease RightOfUseAssetArisingOnNewOfficeLease	582838	usd
CY2022	CEAD	Cashless Exercise Or Prepaid Warrants CashlessExerciseOrPrepaidWarrants	2	usd
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	5577000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	22000000	usd
CY2022	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	On January 17, 2022, the Company’s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty. Such reverse stock split was implemented effective January 27, 2022.
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	240125224	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1600835	shares
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_845_eus-gaap--UseOfEstimates_zH0bTXVN3ZI1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_zeoJykS4ip64">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets as it applies to impairment analysis, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, inventory allowances, and legal contingencies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p>
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q4	us-gaap	Cash Cash	18637000	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	18387000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	127233	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	181942	usd
CY2022	CEAD	Contract With Customer Liability Revenue Recognized Percentage ContractWithCustomerLiabilityRevenueRecognizedPercentage	0.82	pure
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	3358578	usd
CY2021	CEAD	Contract With Customer Liability Revenue Recognized Percentage ContractWithCustomerLiabilityRevenueRecognizedPercentage	0.90	pure
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	631064	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11283189	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13638558	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4338570	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2839838	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2318935	usd
CY2022Q4	CEAD	Remaining Performance Obligations Related To Partial Equipment Paid Contracts RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts	5577000	usd
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	5577000	usd
CY2022	us-gaap	Standard Product Warranty Description StandardProductWarrantyDescription	The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	180457	usd
CY2021Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	186605	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_z0IOfA6bQ7Ah" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zRgx2PYLmp8a">Concentrations</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three customers accounted for <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zs6H9AkYWbfk" title="Concentration risk percentage">27</span>%, <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zM2uI8NhptU4" title="Concentration risk percentage">26</span>% and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_z7SZXN1gz4e6" title="Concentration risk percentage">11</span>% of the Company’s revenue for the year ended December 31, 2022. Three customers accounted for <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z64NdQTh6z36" title="Concentration risk percentage">24</span>%, <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zFrWknVcvHNf" title="Concentration risk percentage">10</span>% and <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zsYJOjXLBSS6" title="Concentration risk percentage">10</span>% of the Company’s revenue for the year ended December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s accounts receivable from two customers made up <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zhGLrddCC8L5" title="Concentration risk percentage">57</span>% and <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_z8saM9GaYSeg" title="Concentration risk percentage">43</span>%, respectively, of the total balance as of December 31, 2022. The Company’s accounts receivable from two customers made up <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zz2AYDXCSZzj" title="Concentration risk percentage">68</span>%, and <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zlnyKXHH5Egl" title="Concentration risk percentage">23</span>%, respectively, of the total balance as of December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Four suppliers accounted for <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__srt--MajorCustomersAxis__custom--SupplierOneMember_z9cxiNzxgx2j" title="Concentration risk percentage">30</span>%, <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__srt--MajorCustomersAxis__custom--SupplierTwoMember_zogNjpjitxG6" title="Concentration risk percentage">17</span>%, <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__srt--MajorCustomersAxis__custom--SupplierThreeMember_zeEGu0seyXs7" title="Concentration risk percentage">16</span>%, and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__srt--MajorCustomersAxis__custom--SupplierFourMember_zD14J5NZ9Tf4" title="Concentration risk percentage">11</span>% of the Company’s purchases of inventory for the year ended December 31, 2022, and three suppliers accounted for <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__srt--MajorCustomersAxis__custom--SupplierOneMember_zUEAindh2HUh" title="Concentration risk percentage">29</span>%, <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__srt--MajorCustomersAxis__custom--SupplierTwoMember_z2WlodZfgFU8" title="Concentration risk percentage">11</span>% and <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__srt--MajorCustomersAxis__custom--SupplierThreeMember_z7X4qgxDtu3a" title="Concentration risk percentage">10</span>% of the Company’s purchases of inventory for the year ended December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p>
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y1M6D
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	319987	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	469703	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost	89970	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	314081	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	324405	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	314081	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	324405	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0363	pure
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0363	pure
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	111204	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	257961	usd
CY2022	us-gaap	Cost Of Goods And Services Sold Overhead CostOfGoodsAndServicesSoldOverhead	12770	usd
CY2021	us-gaap	Cost Of Goods And Services Sold Overhead CostOfGoodsAndServicesSoldOverhead	13589	usd
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2022	CEAD	Increase In Rent Percent IncreaseInRentPercent	0.03	pure
CY2021Q2	us-gaap	Area Of Land AreaOfLand	6900
CY2021Q2	us-gaap	Payments For Rent PaymentsForRent	5989	usd
CY2021Q3	us-gaap	Payments For Rent PaymentsForRent	11978	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	462874	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	565877	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	118235	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	100139	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	376851	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	486226	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y1M6D
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	124897	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	128643	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	132503	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	136473	usd
CY2022Q4	CEAD	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	11654	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	534170	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	39084	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	495086	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	270555	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	272199	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	155	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1050	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	148608	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	196456	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	70907	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	91379	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	348411	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	378326	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	293389	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	289472	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	224876	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	212126	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	68513	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	77346	usd
CY2022	us-gaap	Depreciation Depreciation	32442	usd
CY2021	us-gaap	Depreciation Depreciation	64937	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	24543	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	24543	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-22713	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-22713	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1830	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1830	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	434	usd
CY2022	CEAD	Impairment Of Intangible Assets ImpairmentOfIntangibleAssets	0	usd
CY2021	CEAD	Impairment Of Intangible Assets ImpairmentOfIntangibleAssets	8110	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	311162	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	616056	usd
CY2022Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	25951	usd
CY2021Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	27592	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	465094	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	322873	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	180457	usd
CY2021Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	186605	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	224594	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	192463	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1207258	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1345589	usd
CY2021Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	514200	usd
CY2021Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.01	pure
CY2021Q1	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2026-02-05
CY2021	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	2832	usd
CY2021Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	514200	usd
CY2021Q4	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	2832	usd
CY2021Q3	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	1260000	usd
CY2021Q4	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	1365000	usd
CY2022Q4	CEAD	Redemption Value Adjustment RedemptionValueAdjustment	67000	usd
CY2022Q1	us-gaap	Common Stock Convertible Conversion Price Increase CommonStockConvertibleConversionPriceIncrease	8.55
CY2022	CEAD	Deemed Dividend Preferred Stock On Down Round DeemedDividendPreferredStockOnDownRound	439999	usd
CY2021	CEAD	Common Shares Issued In Settlement Of Legal Dispute CommonSharesIssuedInSettlementOfLegalDispute	67000	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	150000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	850000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	850000000	shares
CY2022	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	On January 17, 2022, the Company’s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty. Such reverse stock split was implemented effective January 27, 2022.
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	240125224	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1600835	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7953974	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1600835	shares
CY2022Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	Effective January 27, 2022, the Company issued 6,798 shares of common stock to round up partial shares resulting from the reverse share split described above
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	22000000	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	169530	shares
CY2022Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	170382	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7953974	shares
CY2021Q2	CEAD	Common Shares Issued In Settlement Of Legal Dispute CommonSharesIssuedInSettlementOfLegalDispute	67000	usd
CY2021	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	7719	shares
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	39368	usd
CY2021	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	28080	usd
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1600835	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1600835	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	50417	shares
CY2020Q4	CEAD	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	50417	shares
CY2020Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	37.50
CY2021	CEAD	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Terms SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms	P6M
CY2021	CEAD	Class Of Warrant Or Right Issued ClassOfWarrantOrRightIssued	222719	shares
CY2021	CEAD	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableGranted	222719	shares
CY2021	CEAD	Class Of Warrant Or Right Weighted Average Exercise Price Issued ClassOfWarrantOrRightWeightedAverageExercisePriceIssued	9.59
CY2021	CEAD	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Issued Weighted Average Remaining Contractual Terms SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingContractualTerms	P36M
CY2021	CEAD	Class Of Warrant Or Right Weighted Average Exercise Price Exercised ClassOfWarrantOrRightWeightedAverageExercisePriceExercised	0.00
CY2021	CEAD	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	-50417	shares
CY2021	CEAD	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExpirations	-50417	shares
CY2021	CEAD	Class Of Warrant Or Right Weighted Average Exercise Price Expired ClassOfWarrantOrRightWeightedAverageExercisePriceExpired	37.50
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	227719	shares
CY2021Q4	CEAD	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	227719	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	9.59
CY2022	CEAD	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Terms SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms	P33M
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	0	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	7566435	shares
CY2022	CEAD	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableGranted	7566435	shares
CY2022	CEAD	Class Of Warrant Or Right Weighted Average Exercise Price Granted ClassOfWarrantOrRightWeightedAverageExercisePriceGranted	4.89
CY2022	CEAD	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Granted Weighted Average Remaining Contractual Terms SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerms	P50M
CY2022	CEAD	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Granted SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted	141434	usd
CY2022	CEAD	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	-170382	shares
CY2022	CEAD	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExercised	-170382	shares
CY2022	CEAD	Class Of Warrant Or Right Weighted Average Exercise Price Exercised ClassOfWarrantOrRightWeightedAverageExercisePriceExercised	0.01
CY2022	CEAD	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Exercised SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised	141434	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	7623772	shares
CY2022Q4	CEAD	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	7623772	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5.14
CY2022	CEAD	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm	P49M
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	7623772	shares
CY2022Q4	CEAD	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	7623772	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P49M
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	22000000	usd
CY2022Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	290557	shares
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	761670	shares
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1154000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-281000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-217000	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-53000	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	7000	usd
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-124000	usd
CY2022	CEAD	Income Tax Reconciliation True Up Adjustments IncomeTaxReconciliationTrueUpAdjustments	164000	usd
CY2021	CEAD	Income Tax Reconciliation True Up Adjustments IncomeTaxReconciliationTrueUpAdjustments	9000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-30000	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-13000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1230000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	462000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	6474000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5262000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	252000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	177000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	94000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	141000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	6820000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	5580000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	88000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	78000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	88000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	78000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	6732000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	5502000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6732000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5502000	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	25949000	usd
CY2022Q4	CEAD	Net Operating Loss Carry Forward Expected To Expire Amount NetOperatingLossCarryForwardExpectedToExpireAmount	11196000	usd
CY2022	CEAD	Net Operating Loss Expiration Term NetOperatingLossExpirationTerm	2034 through 2037
CY2017Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	14753000	usd
CY2022Q4	CEAD	Nols Usage Against Taxable Income Percentage NolsUsageAgainstTaxableIncomePercentage	0.80	pure
CY2022	CEAD	Nols Carryforwards Term Description NolsCarryforwardsTermDescription	three-year period
CY2022Q1	CEAD	Percentage Of Overallotment PercentageOfOverallotment	0.15	pure

Files In Submission

Name	View Source	Status
0001493152-23-009274-index-headers.html	Edgar Link	pending
0001493152-23-009274-index.html	Edgar Link	pending
0001493152-23-009274.txt	Edgar Link	pending
0001493152-23-009274-xbrl.zip	Edgar Link	pending
cead-20221231.xsd	Edgar Link	pending
ex21-1.htm	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
ex4-8.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
cead-20221231_lab.xml	Edgar Link	unprocessable
cead-20221231_cal.xml	Edgar Link	unprocessable
cead-20221231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cead-20221231_def.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CEAD
CEA Industries Inc. Stock $cead

2023 Q1 Form 10-K Financial Statement

#000149315223009274 Filed on March 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CEAD CEA Industries Inc. Stock $cead

2023 Q1 Form 10-K Financial Statement

#000149315223009274 Filed on March 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CEAD
CEA Industries Inc. Stock $cead